| | Intensive Performance Protocol | 10mg subcutaneous, 5x/week (weekdays) | 150mg oral, daily | Both compounds AM, pre-training | 6 weeks on, 4 weeks off | Athletic performance research, substrate utilization studies, endurance capacity trials | Higher dosing frequency and dose intensity produce more pronounced short-term shifts in RER and VO2 max, but require stricter adherence and increase washout sensitivity
2019 May;41(5):420-427
This decision should be made with your prescribing healthcare provider and depends on multiple factors, including how much weight you still need to lose, the severity of the hair loss, and whether correctable causes like nutritional deficiencies are contributing
While our lawyers are not actively pursuing Ozempic gallbladder lawsuits, studies that identified this risk also should have resulted in stronger warnings about the risk of more severe and long-lasting gastroparesis problems
Research indicates that a GLP-1 receptor agonist aids in fat loss by signaling satiety and reducing appetite